CRLF2 and acute lymphoblastic leukemia: Because deregulated CRLF2 expression has been described in patients with BCP-ALL lacking the above-mentioned genetic aberrations, the results suggest that only a subclone of leukemic cells carries this aberration sufficiently to drive CRLF2 overexpression.